| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| VERV | Verve Therapeutics, Inc. | ADELMAN BURT A | Director | May 12, 2022 | Buy | $12.15 | 10,000 | 121,526 | 18,700 | May 13, 2022, 04:37 PM | |
| VERV | Verve Therapeutics, Inc. | ADELMAN BURT A | Director | Mar 15, 2022 | Buy | $21.38 | 4,000 | 85,535 | 8,700 | Mar 17, 2022, 07:58 AM | |
| VERV | Verve Therapeutics, Inc. | ADELMAN BURT A | Director | Dec 02, 2021 | Buy | $31.34 | 4,700 | 147,304 | 4,700 | Dec 06, 2021, 08:11 AM | |
| DYAX | DYAX CORP | ADELMAN BURT A | CMO & EVP, R&D | Jan 13, 2016 | Option Exercise | $1.50 | 142,977 | 214,688 | 208,602 | Jan 15, 2016, 04:20 PM | |
| DYAX | DYAX CORP | ADELMAN BURT A | CMO & EVP, R&D | Dec 22, 2015 | Option Exercise | $1.48 | 10,000 | 14,800 | 65,625 | Dec 22, 2015, 04:11 PM | |
| DYAX | DYAX CORP | ADELMAN BURT A | CMO & EVP, R&D | Dec 17, 2015 | Option Exercise | $1.48 | 27,500 | 40,700 | 55,625 | Dec 18, 2015, 04:17 PM | |
| DYAX | DYAX CORP | ADELMAN BURT A | CMO & EVP, R&D | Mar 05, 2015 | Sale | $15.66 | 9,375 | 146,843 | 28,125 | Mar 06, 2015, 04:16 PM | |
| DYAX | DYAX CORP | ADELMAN BURT A | CMO & EVP, R&D | Jan 02, 2015 | Sale | $7.77 | 150,000 | 1,164,863 | 112,500 | Jan 05, 2015, 06:43 PM | |
| DYAX | DYAX CORP | ADELMAN BURT A | CMO & EVP, R&D | Feb 27, 2014 | Option Exercise | $10.20 | 37,500 | 382,500 | 37,500 | Mar 03, 2014, 06:58 PM | |
| DYAX | DYAX CORP | ADELMAN BURT A | CMO & EVP, R&D | Mar 03, 2014 | Sale | $5.58 | 110,000 | 613,800 | 92,500 | Mar 03, 2014, 06:58 PM |
Menu